Found: 6
Select item for more details and to access through your institution.
Vascular-Targeted Therapy for Systemic Lupus Erythematosus–Associated Vasculitis.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 4, p. 460, doi. 10.1001/jamadermatol.2023.0077
- By:
- Publication type:
- Article
Type I Interferon–Activated STAT4 Regulation of Follicular Helper T Cell–Dependent Cytokine and Immunoglobulin Production in Lupus.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 3, p. 478, doi. 10.1002/art.41532
- By:
- Publication type:
- Article
Stand Together and Deliver: Challenges and Opportunities for Rheumatology Education During the COVID‐19 Pandemic.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 7, p. 1064, doi. 10.1002/art.41278
- By:
- Publication type:
- Article
Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D<sub>3</sub> on the Interferon Signature in Patients With Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 7, p. 1848, doi. 10.1002/art.39108
- By:
- Publication type:
- Article
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 12, p. 2185, doi. 10.1002/art.42652
- By:
- Publication type:
- Article
Evaluating the risk of QTc prolongation associated with hydroxychloroquine use with antidepressants in lupus patients with fibromyalgia.
- Published in:
- Lupus, 2021, v. 30, n. 11, p. 1844, doi. 10.1177/09612033211034562
- By:
- Publication type:
- Article